Zoetis Inc. Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31)
Zoetis Inc. (ZTS) reported Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) of -$14.00 million for the 12-month period ending 2013-12-31, per its 10-K filed 2016-02-24.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveAccrualAdjustment · last filed 2016-02-24
- Zoetis Inc. restructuring reserve, accrual adjustment (deprecated 2016-01-31) for the quarter ending 2013-12-31 was $0.00.
- Zoetis Inc. restructuring reserve, accrual adjustment (deprecated 2016-01-31) for the quarter ending 2013-09-29 was $0.00.
- Zoetis Inc. restructuring reserve, accrual adjustment (deprecated 2016-01-31) for the quarter ending 2013-06-30 was $0.00.
- Zoetis Inc. restructuring reserve, accrual adjustment (deprecated 2016-01-31) for the quarter ending 2013-03-31 was -$14.00M.
- Zoetis Inc. restructuring reserve, accrual adjustment (deprecated 2016-01-31) for fiscal 2013 was -$14.00M.
| Period end | Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) 3 month | Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) 6 month | Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) 9 month | Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $0.00 derived: sum of 2 quarters · filed 2016-02-24 | $0.00 derived: sum of 3 quarters · filed 2016-02-24 | -$14.00M 10-K · filed 2016-02-24 |
| 2013-09-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $0.00 derived: sum of 2 quarters · filed 2013-11-13 | -$14.00M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$14.00M 10-Q · filed 2013-08-14 | ||
| 2013-03-31 | -$14.00M 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |